Volume 21, Number 9—September 2015
Dispatch
Laboratory Testing for Middle East Respiratory Syndrome Coronavirus, California, USA, 2013–2014
Mahtab Shahkarami, Cynthia Yen, Carol A. Glaser, Dongxiang Xia, James Watt, and Debra A. Wadford
Table
Respiratory viruses detected in MERS patients under investigation tested by California Department of Public Health, 2013–2014*
| Virus detected | No. patients, N = 52 | % Positive |
|---|---|---|
| Influenza only | 14 | 27 |
| Influenza A (H3) | 10 | 19 |
| Influenza A(H1N1)pdm09 | 3 | 6 |
| Influenza B |
1 |
2 |
| Noninfluenza only | 13 | 25 |
| Respiratory syncytial virus | 1 | 2 |
| Parainfluenza 3 | 2 | 4 |
| Rhinovirus | 3 | 6 |
| Enterovirus | 2 | 4 |
| Human coronavirus 229E | 2 | 4 |
| Adenovirus |
3 |
6 |
| Co-infection | 5 | 10 |
| Influenza A (H3) and rhinovirus | 1 | 2 |
| Influenza A(H1N1)pdm09 and rhinovirus | 1 | 2 |
| Influenza B and rhinovirus | 2 | 4 |
| Parainfluenza 3 and rhinovirus |
1 |
2 |
| No. patients with detected virus | 32 | 62 |
*MERS, Middle East respiratory syndrome.
Page created: August 14, 2015
Page updated: August 14, 2015
Page reviewed: August 14, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.